IHM
MGNX icon

Iguana Healthcare Management’s MacroGenics MGNX Stock Holding History

Iguana Healthcare Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-80,000
Closed -$2.39M – 74
2016
Q3 		$2.39M Buy
80,000
+5,000
+7% +$149K 0.43% 62
2016
Q2 		$2.02M Buy
+75,000
New +$1.69M 0.82% 39

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Iguana Healthcare Management's MGNX Position: Q4 2016 in Review

Iguana Healthcare Management sold out of MacroGenics (MGNX) in Q4 2016, closing a stake of 80,000 shares — an estimated $2.39M sold.

Iguana Healthcare Management first reported a position in MGNX in Q2 2016 and held it in 2 quarters. The position peaked at $2.39M in Q3 2016. 131 funds tracked by Wall St. Rank hold MGNX as of Q4 2016.

  • Iguana Healthcare Management reported no remaining MacroGenics position as of Q4 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 80,000 MacroGenics shares in Q4 2016, an estimated $2.39M.
  • Iguana Healthcare Management first reported a position in MacroGenics in Q2 2016 and held it in 2 quarters.
  • Iguana Healthcare Management's MacroGenics position peaked at $2.39M in Q3 2016.
  • 131 funds tracked by Wall St. Rank held MacroGenics as of Q4 2016.

Based on Iguana Healthcare Management's 13F filing for Q4 2016, filed 14 Feb 2017.